A1 Refereed original research article in a scientific journal

Expression of toll-like receptors in recurrent pleomorphic adenoma and carcinoma ex pleomorphic adenoma




AuthorsJauhiainen, Maria K; Markkanen, Anttoni; Atula, Timo; Aro, Katri; Haglund, Caj; Söderlund-Venermo, Maria; Mäkitie, Antti A; Sinkkonen, Saku T; Hagström, Jaana

PublisherJohn Wiley & Sons

Publication year2025

JournalAPMIS

Journal name in sourceAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Journal acronymAPMIS

Volume133

Issue1

ISSN0903-4641

eISSN1600-0463

DOIhttps://doi.org/10.1111/apm.13505

Web address https://onlinelibrary.wiley.com/doi/10.1111/apm.13505

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/478219105


Abstract
Pleomorphic adenoma (PA) is a benign salivary gland tumour that may recur or undergo malignant transformation (CXPA). Toll-like receptors (TLR) mediate immune responses triggered by various agents such as viruses and are related to tumour formation either by stimulating or suppressing their growth, with variation across different tumour entities. We compared TLR immunohistochemical expression in PA, its recurrent counterparts and CXPA and evaluated the effect of virus presence in these tumours. We studied the expression of TLR-2, -3, -5, -7 and -9 in 25 PA, 34 recurrent PA and 15 CXPA tumour samples. In addition, we examined the TLR expression levels in the presence and absence of herpes-, polyoma- and parvovirus DNA in a subset of tumours (n = 20). CXPA expressed significantly more TLR-5 and TLR-9 in the nucleus, cytoplasm and cell membrane compared with benign PA. The presence of virus DNA did not notably affect the TLR expression. TLR expression patterns seem to reflect tumour behaviour but are independent of the presence of viruses tested in this study.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
The study was supported by HusLab, and by State Funding for the Helsinki University Hospital (Y780023053, 2021338, and 2021220), and the University of Helsinki Doctoral Programme of Clinical Research.


Last updated on 2025-30-01 at 15:09